83 related articles for article (PubMed ID: 15511475)
1. Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
Lin FC; Durkin AE; Ferguson MK
Ann Thorac Surg; 2004 Nov; 78(5):1783-9. PubMed ID: 15511475
[TBL] [Abstract][Full Text] [Related]
2. Association between fibrosis around the tumor and postoperative infectious complication in patients with esophageal cancer who underwent preoperative therapy.
Gakuhara A; Yamashita K; Miyazaki Y; Adachi K; Momose K; Saito T; Tanaka K; Makino T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Eguchi H; Doki Y
World J Surg; 2024 Apr; 48(4):914-923. PubMed ID: 38319155
[TBL] [Abstract][Full Text] [Related]
3. Perioperative therapy landscape for locally advanced, resectable esophageal cancer: an updated literature review.
Mukherji R; Alqahtani A; Yin C; Caso R; Noel MS; Khaitan PG
J Thorac Dis; 2023 Jun; 15(6):3466-3487. PubMed ID: 37426147
[TBL] [Abstract][Full Text] [Related]
4. Concurrent radiotherapy cannot provide superiority of surgical oncological outcome and long-term survival rate in locally advanced esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy followed by minimally invasive esophagectomy.
Wang YJ; Bao T; Li KK; Xie XF; He XD; Zhao XL; Guo W
Surg Endosc; 2023 Sep; 37(9):7073-7082. PubMed ID: 37380741
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions.
Jiang M; Hu Y; Lin G; Chen C; Li H
Front Immunol; 2023; 14():1177085. PubMed ID: 37325652
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography-based radiomic analysis for predicting pathological response and prognosis after neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
Oda S; Kuno H; Hiyama T; Sakashita S; Sasaki T; Kobayashi T
Abdom Radiol (NY); 2023 Aug; 48(8):2503-2513. PubMed ID: 37171586
[TBL] [Abstract][Full Text] [Related]
7. Update on Management of Squamous Cell Esophageal Cancer.
Waters JK; Reznik SI
Curr Oncol Rep; 2022 Mar; 24(3):375-385. PubMed ID: 35142974
[TBL] [Abstract][Full Text] [Related]
8. Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.
Kojima T; Shah MA; Muro K; Francois E; Adenis A; Hsu CH; Doi T; Moriwaki T; Kim SB; Lee SH; Bennouna J; Kato K; Shen L; Enzinger P; Qin SK; Ferreira P; Chen J; Girotto G; de la Fouchardiere C; Senellart H; Al-Rajabi R; Lordick F; Wang R; Suryawanshi S; Bhagia P; Kang SP; Metges JP;
J Clin Oncol; 2020 Dec; 38(35):4138-4148. PubMed ID: 33026938
[TBL] [Abstract][Full Text] [Related]
9. Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
Huang J; Xu J; Chen Y; Zhuang W; Zhang Y; Chen Z; Chen J; Zhang H; Niu Z; Fan Q; Lin L; Gu K; Liu Y; Ba Y; Miao Z; Jiang X; Zeng M; Chen J; Fu Z; Gan L; Wang J; Zhan X; Liu T; Li Z; Shen L; Shu Y; Zhang T; Yang Q; Zou J;
Lancet Oncol; 2020 Jun; 21(6):832-842. PubMed ID: 32416073
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
11. Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
Khalafi S; Lockhart AC; Livingstone AS; El-Rifai W
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33105560
[TBL] [Abstract][Full Text] [Related]
12. A novel nomogram to predict the risk of anastomotic leakage in patients after oesophagectomy.
Huang C; Yao H; Huang Q; Lu H; Xu M; Wu J
BMC Surg; 2020 Apr; 20(1):64. PubMed ID: 32252738
[TBL] [Abstract][Full Text] [Related]
13. Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks.
Roh S; Iannettoni MD; Keech J; Arshava EV; Swatek A; Zimmerman MB; Weigel RJ; Parekh KR
Korean J Thorac Cardiovasc Surg; 2019 Feb; 52(1):1-8. PubMed ID: 30834211
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis.
Wang DB; Sun ZY; Deng LM; Zhu DQ; Xia HG; Zhu PZ
Chin Med J (Engl); 2016 Dec; 129(24):2974-2982. PubMed ID: 27958230
[TBL] [Abstract][Full Text] [Related]
15. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Saeki H; Nakashima Y; Zaitsu Y; Tsuda Y; Kasagi Y; Ando K; Imamura Y; Ohgaki K; Ito S; Kimura Y; Egashira A; Oki E; Morita M; Maehara Y
Surg Today; 2016 Mar; 46(3):261-7. PubMed ID: 25740123
[TBL] [Abstract][Full Text] [Related]
16. External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†.
Reinersman JM; Allen MS; Deschamps C; Ferguson MK; Nichols FC; Shen KR; Wigle DA; Cassivi SD
Eur J Cardiothorac Surg; 2016 Jan; 49(1):333-8. PubMed ID: 25724906
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients.
Ling TC; Slater JM; Nookala P; Mifflin R; Grove R; Ly AM; Patyal B; Slater JD; Yang GY
Cancers (Basel); 2014 Dec; 6(4):2356-68. PubMed ID: 25489937
[TBL] [Abstract][Full Text] [Related]
18. Postoperative complications do not affect long-term outcome in esophageal cancer patients.
Lindner K; Fritz M; Haane C; Senninger N; Palmes D; Hummel R
World J Surg; 2014 Oct; 38(10):2652-61. PubMed ID: 24867467
[TBL] [Abstract][Full Text] [Related]
19. Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy.
Juloori A; Tucker SL; Komaki R; Liao Z; Correa AM; Swisher SG; Hofstetter WL; Lin SH
J Thorac Oncol; 2014 Apr; 9(4):534-40. PubMed ID: 24736077
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer.
Lorenzen S; Pauligk C; Homann N; Schmalenberg H; Jäger E; Al-Batran SE
Br J Cancer; 2013 Feb; 108(3):519-26. PubMed ID: 23322206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
